<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04091074</url>
  </required_header>
  <id_info>
    <org_study_id>Ticagrelor in carotid stenting</org_study_id>
    <nct_id>NCT04091074</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting</brief_title>
  <official_title>Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      patients undergoing carotid stenting take dual anti platelet therapy to prevent thrombotic
      complications usually used drugs are aspirin plus clopidogrel but there are patients not
      respond so ticagrelor may be an effective and safe alternative
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>compare efficacy of ticagrelor and clopidogrel in patients undergoing carotid stenting</measure>
    <time_frame>15 days before carotid stenting</time_frame>
    <description>patients undergoing carotid stenting are divided into 2 groups comparing efficacy of ticagrelor and clopidogrel</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare safety of ticagrelor and clopidogrel in patients undergoing carotid stenting</measure>
    <time_frame>15 days before carotid stenting</time_frame>
    <description>Patients undergoing carotid stenting are divided into two groups comparing safety of ticagrelor and clopidogrel</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pattern of carotid stenosis</measure>
    <time_frame>1 year</time_frame>
    <description>Incidence of carotid stenosis in patients come to Assiut university hospitals</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Carotid Stenosis</condition>
  <arm_group>
    <arm_group_label>aspirin + ticagrelor before carotid stenting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients undergoing carotid stenting take aspirin 150 mg + ticagrelor 90mg for 15 days before carotid stenting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>aspirin + clopidogrel before carotid stenting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients undergoing carotid stenting take aspirin 150 mg + clopidogrel 75 mg for 15 days before carotid stenting</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ticagrelor</intervention_name>
    <description>Half of patients undergoing carotid stenting take ticagrelor+aspirin</description>
    <arm_group_label>aspirin + ticagrelor before carotid stenting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clopidogrel</intervention_name>
    <description>Other half ofpatients undergoing carotid stenting take clopidogrel+aspirin</description>
    <arm_group_label>aspirin + clopidogrel before carotid stenting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Carotid stenting</intervention_name>
    <description>Patients with carotid stenosis will undergo carotid stenting</description>
    <arm_group_label>aspirin + clopidogrel before carotid stenting</arm_group_label>
    <arm_group_label>aspirin + ticagrelor before carotid stenting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Ischemis stroke of both sex.

          2. More than 18 years.

          3. Accepting all study requirements.

        Exclusion Criteria:

          1. Refuse to comply with all study requirements.

          2. bleeding tendency or liver diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 12, 2019</study_first_submitted>
  <study_first_submitted_qc>September 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2019</study_first_posted>
  <last_update_submitted>January 16, 2020</last_update_submitted>
  <last_update_submitted_qc>January 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Osama Ibrahim Aboelfath Ibrahim</investigator_full_name>
    <investigator_title>Osama Ibrahim Aboelfath Ibrahim</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clopidogrel</mesh_term>
    <mesh_term>Ticagrelor</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

